story of the week
Insulin Degludec and Glargine U100 Treatment in T1D Patients Prone to Nocturnal Severe Hypoglycaemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomised, controlled, open-label, cross-over trial
Diabetes Obes Metab 2021 Oct 12;[EPub Ahead of Print], U Pedersen-Bjergaard, RM Agesen, JMB Brøsen, AC Alibegovic, HU Andersen, H Beck-Nielsen, P Gustenhoff, TK Hansen, C Hedetoft, TJ Jensen, CB Juhl, AK Jensen, SS Lerche, K Nørgaard, HH Parving, AL Sørensen, L Tarnow, B ThorsteinssonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.